T0	KEYPHRASE-NOTYPES 0 11	Respondents
T1	KEYPHRASE-NOTYPES 42 61	personal experience
T2	KEYPHRASE-NOTYPES 67 85	acute Lyme disease
T3	KEYPHRASE-NOTYPES 89 94	PTLDS
T4	KEYPHRASE-NOTYPES 108 123	close associate
T5	KEYPHRASE-NOTYPES 132 139	disease
T6	KEYPHRASE-NOTYPES 141 146	Table
T7	KEYPHRASE-NOTYPES 157 163	groups
T8	KEYPHRASE-NOTYPES 186 197	information
T9	KEYPHRASE-NOTYPES 213 232	personal experience
T10	KEYPHRASE-NOTYPES 238 250	Lyme disease
T11	KEYPHRASE-NOTYPES 254 259	PTLDS
T12	KEYPHRASE-NOTYPES 272 291	personal experience
T13	KEYPHRASE-NOTYPES 297 309	Lyme disease
T14	KEYPHRASE-NOTYPES 319 324	PTLDS
T15	KEYPHRASE-NOTYPES 341 360	personal experience
T16	KEYPHRASE-NOTYPES 366 371	PTLDS
T17	KEYPHRASE-NOTYPES 388 407	personal experience
T18	KEYPHRASE-NOTYPES 413 425	Lyme disease
T19	KEYPHRASE-NOTYPES 431 437	groups
T20	KEYPHRASE-NOTYPES 449 454	PTLDS
T21	KEYPHRASE-NOTYPES 473 490	chronic condition
T22	KEYPHRASE-NOTYPES 509 519	many years
T23	KEYPHRASE-NOTYPES 548 554	groups
T24	KEYPHRASE-NOTYPES 566 571	PTLDS
T25	KEYPHRASE-NOTYPES 624 643	uncertainty ratings
T26	KEYPHRASE-NOTYPES 654 663	questions
T27	KEYPHRASE-NOTYPES 714 725	uncertainty
T28	KEYPHRASE-NOTYPES 742 748	groups
T29	KEYPHRASE-NOTYPES 757 767	experience
T30	KEYPHRASE-NOTYPES 773 778	PTLDS
T31	KEYPHRASE-NOTYPES 780 791	Uncertainty
T32	KEYPHRASE-NOTYPES 806 814	severity
T33	KEYPHRASE-NOTYPES 819 833	chronic nature
T34	KEYPHRASE-NOTYPES 837 842	PTLDS
T35	KEYPHRASE-NOTYPES 871 881	experience
T36	KEYPHRASE-NOTYPES 894 901	disease
T37	KEYPHRASE-NOTYPES 923 933	experience
T38	KEYPHRASE-NOTYPES 939 951	Lyme disease
T39	KEYPHRASE-NOTYPES 961 966	PTLDS
T40	KEYPHRASE-NOTYPES 993 1008	faculty members
T41	KEYPHRASE-NOTYPES 1014 1024	experience
T42	KEYPHRASE-NOTYPES 1030 1035	PTLDS
T43	KEYPHRASE-NOTYPES 1044 1059	similar pattern
T44	KEYPHRASE-NOTYPES 1077 1085	question
T45	KEYPHRASE-NOTYPES 1089 1093	ease
T46	KEYPHRASE-NOTYPES 1097 1106	treatment
T47	KEYPHRASE-NOTYPES 1111 1121	resolution
T48	KEYPHRASE-NOTYPES 1125 1132	disease
T49	KEYPHRASE-NOTYPES 1134 1139	Table
T50	KEYPHRASE-NOTYPES 1144 1155	Respondents
T51	KEYPHRASE-NOTYPES 1181 1188	opinion
T52	KEYPHRASE-NOTYPES 1203 1212	aetiology
T53	KEYPHRASE-NOTYPES 1216 1221	PTLDS
T54	KEYPHRASE-NOTYPES 1250 1256	answer
T55	KEYPHRASE-NOTYPES 1265 1299	ongoing host inflammatory response
T56	KEYPHRASE-NOTYPES 1313 1334	previous Lyme disease
T57	KEYPHRASE-NOTYPES 1350 1370	persistent infection
T58	KEYPHRASE-NOTYPES 1387 1392	group
T59	KEYPHRASE-NOTYPES 1397 1405	contrast
T60	KEYPHRASE-NOTYPES 1409 1423	large minority
T61	KEYPHRASE-NOTYPES 1443 1454	respondents
T62	KEYPHRASE-NOTYPES 1462 1481	personal experience
T63	KEYPHRASE-NOTYPES 1487 1492	PTLDS
T64	KEYPHRASE-NOTYPES 1504 1523	continued infection
T65	KEYPHRASE-NOTYPES 1530 1549	potential aetiology
T66	KEYPHRASE-NOTYPES 1553 1558	PTLDS
